Table 1 Clinical characteristics of the control and maternal asthma group.
From: The impact of maternal asthma on the preterm infants' gut metabolome and microbiome (MAP study)
Characteristics | Infant with maternal history of asthma n = 9 | Infant without maternal history of asthma (control) n = 9 |
|---|---|---|
Gestational Age, average weeks (range) | 29.7 (24.1–34) | 29.6 (24.3–32.6) |
Average weight, g (range) | 1242 (575–2290) | 1381 (605–2320) |
Male infants, n | 5 | 2 |
C-section, n | 8 | 5 |
Prenatal Betamethasone, n | 9 | 9 |
Premature Rupture of membrane, n | 1 | 2 |
APGAR, average (range) at 1 MOL | 5 (2–8) | 6 (1–8) |
APGAR average (range) at 5 MOL | 8 (3–9) | 7 (3–9) |
Pair of Twins | 2 | 1 |
Family ownership of dog, n | 2 | 6 |
Older siblings in house, n | 2 | 6 |
Current smoking in household, n | 2 | 1 |
Maternal antibiotics during pregnancy, n | 4 | 5 |
Maternal antibiotics during delivery, n | 9 | 7 |
Infant received antibiotics during study period | 7 | 4 |
Infant with required antibiotics for more than 2 days during study period | 4 | 4 |
Intraventricular hemorrhage | 3 | 2 |
ROP | 1 | 0 |
Necrotizing enterocolitis | 0 | 0 |
PDA required medical treatment | 1 | 2 |
Needing home oxygen | 1 | 0 |
Needing G-tube | 1 | 3 |
